Hypofractionated, Image-Guided Radiation Therapy With Proton Therapy for Stage I Non-Small Cell Lung Cancer
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Confirm Grade 3 or higher toxicity rate of hypoIGRT proton therapy in patients with stage I non-small cell lung cancer.
1 year after the end of radiation therapy
Yes
Bradford S Hoppe, MD, MPH
Principal Investigator
University of Florida Proton Therapy Institute
United States: Institutional Review Board
UFPTI 0901 - LU03
NCT00875901
September 2009
April 2032
Name | Location |
---|---|
University of Florida Proton Therapy Institute | Jacksonville, Florida 32206 |